Pancreatic Disorders & Therapy : Citations & Metrics Report
Articles published in Pancreatic Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Pancreatic Disorders & Therapy has got h-index 11, which means every article in Pancreatic Disorders & Therapy has got 11 average citations.
Following are the list of articles that have cited the articles published in Pancreatic Disorders & Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 50 | 25 | 28 | 9 | 1 | 7 | 11 | 21 | 35 | 20 | 33 | 30 | 5 |
Research, Review articles and Editorials |
1 | 0 | 2 | 3 | 7 | 1 | 5 | 5 | 16 | 17 | 17 | 25 | 26 | 5 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
39 | 50 | 18 | 14 | 2 | 0 | 2 | 6 | 5 | 6 | 3 | 2 | 4 | 0 |
Conference proceedings |
0 | 9 | 8 | 0 | 0 | 0 | 21 | 74 | 53 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
19 | 42 | 46 | 48 | 62 | 45 | 39 | 55 | 73 | 39 | 31 | 6 | 0 | 0 |
Journal total citations count | 437 |
Journal impact factor | 1.58 |
Journal 5 years impact factor | 3.08 |
Journal cite score | 3.74 |
Journal h-index | 11 |
Journal h-index since 2019 | 9 |
Important citations (368)
commentary on ?acute pancreatitis as initial demonstration of drug- induced vasculitis? |
|
ct- and mri-based assessment of body composition and pancreatic fibrosis reveals high incidence of clinically significant metabolic changes that affect the quality of life and treatment outcomes of patients with chronic pancreatitis and pancreatic cancer. |
|
biomarkers for early diagnosis of pancreatic cancer. |
|
the effect of erythropoietin to pulmonary injury and mast cells secondary to acute pancreatitis |
|
commentary on ?acute pancreatitis as initial demonstration of drug- induced vasculitis? |
|
the nature and function of immunogenic tumor proteins that characterize pancreatic and colorectal cancer: a review |
|
epigenetics - role as biomarker in cancer diagnosis |
|
osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis |
|
an attempt to evaluate selected aspects of "bone-fat axis" function in healthy individuals and patients with pancreatic cancer. |
|
ras-related nuclear protein ran3b gene is involved in hormone responses in the embryogenic callus of dimocarpus longan lour. |
|
ran promotes the proliferation and migration ability of head and neck squamous cell carcinoma cells. |
|
membrane orientation dynamics of lipid-modified small gtpases. |
|
loss of tumor suppressor merlin results in aberrant activation of wnt/?-catenin signaling in cancer. |
|
dlran3a is involved in hormone, light, and abiotic stress responses in embryogenic callus of dimocarpus longan lour. |
|
ran gtpase is an independent prognostic marker in malignant melanoma which promotes tumour cell migration and invasion. |
|
periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. |
|
knockdown of ran gtpase expression inhibits the proliferation and migration of breast cancer cells |
|
functional blockade of small gtpase ran inhibits glioblastoma cell viability. |
|
lin28a regulates stem-like properties of ovarian cancer cells by enriching ran and hsbp1 mrna and up-regulating its protein expression. |
|
new developments in the early diagnosis of pancreatic cancer |
|